Risques bucco-dentaires liés au cannabidiol (CBD) dans des produits consommés par les personnes âgées : fleurs à fumer, gouttes, tisanes, confiseries, dentifrices, etc.

View at publisher
Authors: Cyril SABLAYROLLES, Astrid GARANDEAU-MADINIER, Isabelle Prêcheur
Cited by: 0

Abstract

Cannabidiol (CBD) comes from Cannabis sativa or it is obtained by synthesis. It is not hallucinogenic and does not induce addiction, and since 2021 “wellness” products containing cannabidiol have been authorized in France, offered against stress, anxiety, sleep disorders and chronic pain. We conducted a survey among pharmacies, tobacco shops and “CBD shops”. The market for seniors is very limited but seems to be growing, and they mainly buy flowers to smoke to mix with tobacco. But there is a high risk of drug interactions and adverse effects (drowsiness, falls, car accidents). Moreover, the long-term consumption of smoked cannabidiol, in herbal teas, candies or toothpaste for example, leads to a topical application of cannabidiol in the mouth. It is also excreted in saliva. As it has anti-inflammatory properties, it could reduce the immune system’s defences against oral infections (cavities, gingivitis, periodontitis, oral candidiasis), which are very common in elderly people. This risk is not described in the health authorities’warnings. In practice, when a patient asks for advice on cannabidiol, the doctor and pharmacist could advise him to consult his dentist.

Fields of Study & Subjects

Cannabis and Cannabinoid Research Complementary and Alternative Medicine Studies Oral microbiology and periodontitis research

Publication details

Journal / source
La Revue de gériatrie
Pages
5–5
Publication date
1 February 2026
Language
EN